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In order to cause the disease anthrax, Bacillus anthracis requires two plasmids, pX01 and pX02, which carry
toxin and capsule genes, respectively, that are used as genetic targets in the laboratory detection of the
bacterium. Clinical, forensic, and environmental samples that test positive by PCR protocols established by the
Centers for Disease Control and Prevention for B. anthracis are considered to be potentially B. anthracis until
confirmed by culture and a secondary battery of tests. We report the presence of 10 genes (acpA, capA, capB,
capC, capR, capD, IS1627, ORF 48, ORF 61, and repA) and the sequence for the capsule promoter normally
found on pX02 in Bacillus circulans and a Bacillus species closely related to Bacillus luciferensis. Tests revealed
these sequences to be present on a large plasmid in each isolate. The 11 sequences consistently matched to B.
anthracis plasmid pX02, GenBank accession numbers AF188935.1, AE011191.1, and AE017335.3. The percent
nucleotide identities for capD and the capsule promoter were 99.9% and 99.7%, respectively, and for the
remaining nine genes, the nucleotide identity was 100% for both isolates. The presence of these genes, which
are usually associated with the pX02 plasmid, in two soil Bacillus species unrelated to B. anthracis alerts us to
the necessity of identifying additional sequences that will signal the presence of B. anthracis in clinical, forensic,
and environmental samples.
Long considered a biowarfare agent, Bacillus anthracis was
used in 2001 in an act of bioterrorism. After bacterial endospores were placed into envelopes and delivered by the United
States postal system to unsuspecting victims, 22 people were
infected of whom 11 developed inhalational anthrax and 5 died
(14, 15). As a result, first responders delivered hundreds of
thousands of environmental specimens to laboratories across
the nation that are part of the National Laboratory Response
Network (LRN), a coordinated system of sentinel, reference,
and national laboratories established by the Centers for Disease Control and Prevention (CDC) (6, 7). Of the three Florida Department of Health (FDOH) laboratories with biosafety
level 3 facilities designated to receive these specimens, the
FDOH Tampa Laboratory received and analyzed 1,046 environmental samples from first responders across west-central
Florida over the last 3 months of 2001. Among these specimens, 19 loose powders or swab samples of powders that were
brought in by local law enforcement officers and considered
plausible threats initially tested positive for potentially carrying
a B. anthracis isolate.
Because of the initial positive results, the 19 powders and
swabs were cultured and all isolates were tested further using
the LRN tests, consisting of nonspecific phenotypic physical/
biochemical tests and specific molecular methods for B. anthracis such as gamma phage susceptibility testing, cell wall and

capsule detection by direct fluorescence antibody tests (DFA),
and amplification of targeted DNA sequences by PCR (31).
After more tests demonstrated that none of these were B.
anthracis, the 19 isolates were given to the Center for Biological Defense for further examination. By in-house real-time
PCR assays, 14 of the 19 isolates and respective powders tested
positive only for the Ba813 chromosomal element, which is
considered to be unique to B. anthracis (19, 22, 23). These were
not studied further. Yet, five environmental isolates of the
Bacillus genus tested positive for Ba813 and pX02 by PCR
and/or showed a positive reaction for the capsule by DFA. The
isolates were later identified as three B. cereus isolates, one B.
circulans isolate, and one Bacillus isolate not determined to
species level.
The DNA targets used for the LRN PCR assay for B. anthracis are sequences that are not specified to LRN personnel
and others. Yet it is known that one DNA target sequence is
located on the chromosome and the other two targets on the
two virulence plasmids, pX01 and pX02 (31). The “toxin”
plasmid pX01 contains the lef, pag, and cya genes encoding
lethal factor, protective antigen, and edema factor, respectively, and is the larger (184 kb) and purportedly more numerous (24 to 243 copies) of the two plasmids (8). The second
plasmid, pX02, is smaller (97 kb) and lower in copy number (1
to 32) and contains a total of 85 open reading frames (ORFs)
including the genes that comprise the capsule operon (8). The
pX02 plasmid has been reported in the highly related species
of B. cereus and B. thuringiensis, but it has never been reported
in Bacillus species outside of the B. cereus group (23). Although some of the pX02 plasmid genes have also been re-
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TABLE 1. Results of initial tests of two non-B. anthracis Bacillus species and two control B. anthracis strainsa
Resultb by:
Strain

63
118
119
131

Species

PCR

B. anthracis
B. circulans
Bacillus sp.f
B. anthracis

DFA

pX01

pX02

Chromosome

Ba813

Capsule

Cell wall

⫺
⫺
⫺
⫺

ⴙ
ⴙ
ⴙ
ⴙ

ⴙ
ⴙ
ⴙ
ⴙ

ⴙ
ⴙ
ⴙ
ⴙ

ⴙ
ⴙd
⫺
ⴙ

ⴙ
⫺
⫺
ⴙ

␥ phage
susceptibility

Hemolysis

Motility

ⴙ
⫺
⫺
ⴙ

NHc
NH
NH
NH

⫺
⫺e
⫺
⫺

a
PCR assays, DFA, and gamma phage testing were performed by FDOH following LRN protocols (31), while Ba813 testing was performed by following a method
previously published (17). All of the LRN tests were repeated by the Center for Biological Defense immediately after receiving these isolates from FDOH personnel.
b
⫺, negative result; ⫹, positive result.
c
NH, nonhemolytic on media with 5% sheep blood cells.
d
CBD 118 was positive for capsule DFA at initial testing; subsequent testing after cryostocking resulted in negative DFA tests. CBD protocols allow minimum
subculturing (one to four subcultures) per cryostock vial.
e
CBD 118 appeared to be nonmotile at first examination, but later testing revealed that the cells were motile.
f
CBD 119 was identified as closely resembling B. luciferensis.

ported in the B. cereus and B. thuringiensis chromosomes, none
of the capsule genes have been reported in other Bacillus
species (3, 5, 10, 21).
Because our initial tests suggested that the two isolates carried one capsule gene, we hypothesized that the full capsule
operon of B. anthracis was present on either the chromosome
or plasmid. We attempted to identify the capsule operon genes
and other ORFs in the two isolates and to determine whether
the genes were located on a plasmid or the chromosome.
(These data were presented as abstract Q-195 at the 105th
General Meeting of the American Society for Microbiology,
Atlanta, Ga., 5 to 9 June 2005.)
MATERIALS AND METHODS
Bacteria culture and phenotypic characterization. Two unidentified Bacillus
isolates (CBD 118 and CBD 119) were isolated from two different environmental
samples that were received by the FDOH, Bureau of Laboratories, on two
different days from local law enforcement personnel. The sample harboring CBD
118 was a “dirty swab” laden with a brown-gray powder, and the other sample
containing CBD 119 was a white powder within a small container. These isolates
and powders were then given to the Center for Biological Defense because,
although the isolates proved not to be B. anthracis, they had given positive results
for the pX02 plasmid and chromosomal element by PCR and/or the DFA used
in the LRN protocols for ruling out B. anthracis (31) (Table 1). Bacillus control
strains used were two B. anthracis Pasteur strains, CBD 63 (derived from CDC
BC 3132) and CBD 131, B. cereus CBD 55 (derived from ATCC 14579), B. cereus
CBD 58 (derived from CDC BC 3133), B. circulans CBD 389 (derived from
ATCC 4513; American Type Culture Collection, Manassas, VA), B. luciferensis
CBD 980 (derived from JCM 12212; Japanese Collection of Microorganisms,
Saitama, Japan), B. megaterium CBD 395 (derived from ATCC 14581), and B.
thuringiensis CBD 61 (derived from ATCC 35646).
Isolates were grown on Trypticase soy agar (TSA) supplemented with 5%
sheep red blood cells (Remel, Lenexa, KS) overnight and were evaluated for
Gram’s stain reaction, cellular and colony morphology, and hemolysis pattern
(11, 17, 18, 26, 31). Motility was determined by examination of overnight growth
in Trypticase soy broth (TSB) (Becton Dickinson and Company, Sparks, MD
[BD]) using phase-contrast microscopy of log-phase cells as described previously
(20). Sporulation was induced on nutrient agar (BD) supplemented with 5
mg/liter MnSO4 and incubated for 48 to 72 h. Endospore shape and location,
swelling of the vegetative cell, and the presence of parasporal bodies were
observed in wet mounts by phase-contrast microscopy. Lecithinase production,
mannitol fermentation, and tolerance of polymyxin B were tested on mannitolegg yolk-polymyxin B agar, as previously described (20). Acid production from 49
carbohydrates or carbohydrate derivatives after 48 h of incubation at 30°C was
tested using the API 50 CH panel with API CHB/E medium in combination with
11 biochemical tests from the API 20E kit, including tests for ␤-galactosidase
activity, citrate utilization, and urea and gelatin hydrolysis, the Voges-Proskauer
test for acetoin production, and nitrate reduction testing, by following the man-

ufacturer’s instructions (bioMerieux, Inc., Hazelwood, MO). Profiles were analyzed and identifications obtained using the APILAB Plus identification program, V.3.3.3/3.0 (bioMerieux).
To determine whether there was capsule production by the two Bacillus isolates, they were grown on Biolog universal growth agar (BUG) and TSA with and
without 0.8% sodium bicarbonate in 5% CO2 at 35°C for 15 h by following the
LRN protocol (31). In addition, capsule formation was examined after growth in
an approximately 20% CO2 atmosphere as previously described (12). Isolated
colonies were suspended in 60 l sterile water and adjusted to a 2 McFarland
standard optical density. One drop of India ink (Becton Dickinson) was added to
the bacterial suspension and mixed. Three microliters of this bacterium-ink
mixture was placed on a microscope slide and observed at 1,000⫻ with phase
contrast. Control strains were B. anthracis Pasteur CBD 63 (positive) and B.
cereus CBD 58 (negative). All DFA tests were repeated by FDOH personnel
following the LRN protocols and using the same DFA reagents and control
strains.
16S rRNA gene sequencing. DNA was extracted from cells grown overnight in
TSB using the MasterPure gram-positive DNA purification kit (Epicenter, Madison, WI). PCR for the 16S rRNA gene amplicon used primers TU102 (5⬘-AGA
GTT TGA TCA/C TGG-3⬘) and TU103 (5⬘-TAC CTT GTT ACG ACT-3⬘),
comparable to primers 27F and 1492R, respectively, used by Herrick et al. (13).
The PCR parameters were as follows: initial heating at 94°C for 4 min followed
by 30 cycles of 1 min at 94°C, 2 min at 37°C, and 2 min at 72°C and a final
extension at 72°C for 6 min. The amplicon was purified with Montage PCR
centrifugal filter devices (Millipore Corporation, Billerica, MA). Sequencing was
performed by the Oklahoma Medical Research Foundation DNA sequencing
facility using the ABI 3730 capillary sequencer (Applied Biosystems, Foster City,
CA) with primers TU102 (27F), TU108 (926F), D907R, and 704F (13, 16).
Sequencher (Windows version 4.2; Gene Codes Corp., Ann Arbor, MI) was used
to assemble the fragments and to examine the sequences for the presence of
conserved regions. The sequencing data were analyzed by comparison of the
consensus sequences with the GenBank database (National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD) (http://www
.ncbi.nlm.nih.gov/BLAST/) using BLASTN 2.2.12 software (1, 4), and the percentages of similarity to closely related sequences were determined using 1,495
bp (01/06). GenBank bl2seq (29) was used to make the pairwise alignments
(01/2006).
Retesting original sample powders. Total DNA was extracted from the original environmental specimens and used as template in a PCR assay for Ba813, an
intergenic chromosomal marker for B. anthracis, as previously described (19, 22).
In addition, the PCR assays for the pX01 and pX02 plasmids and chromosomal
marker were repeated following LRN procedures (31).
DNA extraction. Total DNA was extracted from overnight bacterial growth in
TSB using the MasterPure gram-positive DNA purification kit (Epicenter) by
following the manufacturer’s directions. Plasmid DNA was obtained using the
QIAGEN Inc. (Valencia, CA) plasmid Midi kit by following the manufacturer’s
“very low copy number plasmid” protocol. Concentrated DNA was stored at
⫺30°C, while diluted DNA used for PCR and sequencing was stored at 4°C until
needed.
Plasmid restriction digestion. Restriction digestions were performed with 0.3
l bovine serum albumin (10 mg/ml), 3 l 10⫻ buffer, 20 to 24 units of restriction
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enzyme, and approximately 1 g plasmid DNA in 30-l volumes (9). Enzymes
used were EcoNI (New England BioLabs, Beverly, MA), KpnI, MluI, NotI, PvuI,
and XhoI (Promega, Madison, WI). We chose these enzymes after performing a
virtual digestion on both the LaserGene MapDraw program (DNAStar, Madison, WI) and a free website at http://restrictionmapper.org (last update 18 January 2003 and last accessed 5 April 2006). Digestion mixtures were incubated for
4 h at optimal temperature for complete digestion and stored at ⫺20°C until
needed. B. anthracis Pasteur CBD 63 and B. anthracis CBD 131 were used for
comparison. The expected number of DNA bands produced by each digestion
was determined by the restrictionmapper and MapDraw programs and were as
follows: EcoNI, 10 bands (108, 229, 1,328, 3,344, 4,445, 8,487, 10,658, 16,355,
18,608, and 32,658 bp); KpnI, 4 bands (3,184, 7,712, 23,206, and 62,129 bp); MluI,
3 bands (2,136, 36,871, and 57,224 bp); NotI, 1 band (96,231 bp); PvuI, 4 bands
(11,833, 26,226, 26,889, and 31,282 bp); XhoI, 2 bands (14,426 and 81,805 bp).
KpnI, MluI, NotI, and XhoI were not expected to cut within any of the targeted
sequences. PvuI was expected to cut into the capD gene at location 53115. EcoNI
was expected to cut into three targeted genes, repA (location 32669), capD
(location 53577), and capA (location 54905). Digestions were repeated to confirm all findings.
PCR. Besides the capsule operon genes, we chose ORFs on pX02 that, to our
knowledge, have not been previously identified in B. cereus or B. thuringiensis in
either the chromosome or plasmids (21). Together, these sequences comprise
only 10.3% of the total plasmid. Primers were designed using LaserGene
(DNAStar) and the B. anthracis pX02 sequence obtained from GenBank (accession number NC_002146) (Table 2 and Fig. 1). PCRs on 10-l mixtures (1.5
mM MgCl2, 1⫻ buffer, 2 M deoxynucleoside triphosphate, 1.3 M primers,
0.025 U Taq DNA polymerase; Takara, Madison, WI) were carried out using 10
to 100 ng plasmid-rich template in a T1 thermocycler (Biometra, Horsham, PA)
with the following parameters: initial heating for 2 min at 94°C, followed by 40
cycles of 20 seconds at 94°C, 20 seconds at 58 to 70°C, and 3 min at 72°C, with
a final extension at 72°C for 7 min. When the desired amplicon was ⬎1 kb in
length, the melting and annealing times were increased to 1 min each. Positive
(B. anthracis Pasteur CBD 63 and B. anthracis CBD 131) and negative (B. cereus
CBD 58 and distilled water [dH2O]) controls were used for all assays.
Electrophoresis. The plasmid preparations and genomic DNA were electrophoresed on a 0.7% DNA grade agarose gel (Fisher Scientific International, Inc.,
Hampton, NH) (0.5⫻ Tris-borate-EDTA [TBE]) for 90 to 120 min at 60 V
constant voltage. Digested DNA was electrophoresed for 4 h at 100 V constant
voltage. DNA bands were visualized with UV light after staining with 0.5 g/ml
ethidium bromide for 15 min and destained twice for 15 min in dH2O. Photographs of the stained gels were made using the GelDoc (Bio-Rad, Hercules, CA).
PCR products were separated on a 1% agarose gel (0.5⫻ TBE with 0.05 g/ml
ethidium bromide) for 60 min at 100 V constant voltage. Staining and destaining
were not necessary for the 1% gels.
DNA-DNA hybridization. DNA dot blots containing 10 to 100 g purified total
or plasmid DNA and Southern blots from gels were made using an ImmobilonnYplus nylon membrane (Millipore, Bedford, MA) or Roche nylon membrane
(Roche Diagnostics, Indianapolis, IN) and prepared by following standard protocols (25). The DNA was bound to the membrane by UV irradiation using the
Spectrolinker XL1000 (Spectronics Corporation, Westbury, NY). Oligonucleotide probes specific for internal portions of the targeted genes were designed with
LaserGene (DNAStar) (Table 2) and labeled with digoxigenin using the DIG
oligonucleotide tailing kit (Roche) in accordance with the manufacturer’s instructions. Oligonucleotide probes specific for Ba813 and LRN chromosomal
sequence were used to ensure that there was no chromosomal contamination of
Southern blots (19). The different probes detected as little as 2 ng of positive
DNA. Positive (B. anthracis Pasteur CBD 63 and CBD 131) and negative controls (B. cereus CBD 58 and dH2O) were used with each assay.
Sequencing. Different combinations of forward and reverse primers were
tested to determine which pairs produced large amplicons that could be used as
a template for the sequencing PCRs (Tables 2 and 3 and Fig. 1). The amplicons
from the PCR assays were purified using the Wizard PCR prep kit (Promega,
Madison, WI) in accordance with the manufacturer’s protocol before use as a
template. Additional oligonucleotide primers were designed (Table 2 and Fig. 1)
and were used in 25-pmol amounts in dye incorporation PCR cycle sequencing
using the CEQ DTCS Quick Start kit (Beckman-Coulter, Fullerton, CA). Sequencing conditions were as follows: 30 cycles of 96°C for 20 seconds, 50°C for
20 seconds, and 60°C for 4 min. The amplicon was held at 4°C until it was
precipitated, dried, and resuspended in sample loading solution (Beckman)
overlaid with mineral oil and loaded into the CEQ 8000 sequencer (BeckmanCoulter) by following the company protocol. All reactions were performed multiple times, and sequences were obtained in both directions. Contiguous sequences were assembled with the SeqMan program of LaserGene (DNAStar)
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and compared with four B. anthracis plasmid GenBank sequences for B. anthracis
Pasteur (accession numbers NC_002146.1), B. anthracis Ames (accession number
AE017335.3), B. anthracis A2012 (accession number AE011191.1), and B. anthracis (accession number AF188935.1) using the NCBI BLASTN software (1, 4)
(http://www.ncbi.nlm.nih.gov/BLAST/) (01/06). Sequences from CBD 118 and
119 have been submitted to GenBank.
Nucleotide sequence accession numbers. Nucleotide sequences obtained in
this study were deposited in the GenBank database under accession numbers
DQ374636 and DQ374637 (16S rRNA gene sequences of CBD 118 and CBD
119, respectively). GenBank accession numbers for CBD 118 (B. circulans) gene
sequences obtained in this study are as follows: DQ517343 (acpA), DQ517347
(for capA, capB, and capC together), DQ517352 (capD), DQ517350 (capR),
DQ517353 (repA), DQ517341 (ORF 48), DQ517345 (ORF 61), DQ517355
(IS1627), and DQ517357 (capsule promoter sequence). GenBank accession
numbers for CBD 119 (Bacillus species) are as follows: DQ517344 (acpA),
DQ517348 (for capA, capB, and capC together), DQ517351 (capD), DQ517349
(capR), DQ517354 (repA), DQ517342 (ORF 48), DQ517346 (ORF 61), DQ
517356 (IS1627), and DQ517358 (capsule promoter sequence).

RESULTS
Both CBD 118 and CBD 119 were nonhemolytic, penicillin
susceptible, and nonmotile on the first examination. Using our
laboratory protocol for determining motility, CBD 118 was
clearly motile while CBD 119 was confirmed to be nonmotile.
Both isolates produced ellipsoidal, subterminal endospores
without evidence of parasporal crystal formation. Endosporedriven swelling of CBD 118 was subtle to occasionally pronounced, while overt swelling was seen for CBD 119. Both
CBD 118 and 119 failed to grow on the mannitol-egg yolkpolymyxin B media, whereas B. cereus CBD 55, B. anthracis
Pasteur CBD 63, and B. thuringiensis CBD 61 thrived, fermented mannitol, and were lecithinase⫹. CBD 118 was twice
identified by the API system as Bacillus circulans biotype 1
(“very good identification”; % confidence in identification
[%ID] ⫽ 99.4%). Two tests of CBD 119 in the API panels
resulted in an “identification not valid,” with Bacillus amyloliquefaciens (%ID ⫽ 77.6%), B. subtilis (%ID ⫽ 9.4%), B. lentus
(%ID ⫽ 5.8%), B. cereus (%ID ⫽ 3.3%), and Brevibacillus
laterosporus (%ID ⫽ 3.1%) proposed as significant taxa, and a
“doubtful profile” with the significant taxon of B. laterosporus
(%ID ⫽ 99.4%).
When 1,495 bp of 16S rRNA gene sequence was compared
to those in the GenBank database, CBD 118 shared 1,454/
1,458 bp (99.7%) with unpublished Bacillus benzoevorans (accession number AY043085), 1,477/1,495 bp (98.7%) with Bacillus circulans N3 (accession number AB215100), and 1,470/
1,489 bp (98.7%) with B. circulans ATCC 4513 (accession
number AY724690). When compared with B. anthracis Ames
(accession number AE017024), CBD 118 had less than the
requisite 97% sequence similarity (1,399/1,490 bp [93.9%]) for
relatedness at the species level (27, 28). Based upon the API
system results and 16S rRNA gene sequence similarities, CBD
118 was identified as a Bacillus circulans.
CBD 119 shared 1,478/1,488 bp (99.3%) with Bacillus luciferensis LMG 18422 (accession number AJ419629), the only
named Bacillus sp. with which the isolate had greater than 97%
sequence similarity. CBD 119 shared 1,414/1,487 bp (95.1%)
with B. anthracis Ames (accession number AE017024) and
1,196/1,311 bp (91.2%) with B. laterosporus BL-2 (accession
number DQ371289). No Brevibacillus sp. in the GenBank database shared ⱖ97% 16S sequence similarity with CBD 119.
Therefore, CBD 119 was identified by 16S rRNA gene se-
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TABLE 2. Oligonucleotides used as primers and probes for PCR assays for plasmid sequences
Gene or ORF

Primer b

Sequence (5⬘33⬘)

Location

Length
(bp)

Source or
reference

acpA (partial)

acpA2F
acpA5R
acpA3F a
acpA3Ra

AGC-CGA-AAA-ATT-GAT-TTG-TTA-AAT-ATC-CTA-ATT
CAC-TCC-TGG-TAA-TAT-CAT-CGG-AAA-TCG-GTT-AT
GAA-TTG-TAG-GGG-ATG-AAT-TTC-AAA-TTA-TAC-TAA-TG
TTC-CCC-CTC-TTT-GTA-AAG-TAC-TAA-TTC-TTC-TTG

68924–68956
70546–70577
68324–68358
69731–69763

1,653

This
This
This
This

study
study
study
study

acpA (partial)

acpA1F
acpA4R
acpA3F a
acpA3Ra

GTT-ATG-TTT-GAT-ATC-CCC-TGA-TGT-TAC-CAA-TT
CTC-CTA-CAA-ATT-TTA-ATT-GAT-CGC-CAT-AAC-G
GAA-TTG-TAG-GGG-ATG-AAT-TTC-AAA-TTA-TAC-TAA-TG
TTC-CCC-CTC-TTT-GTA-AAG-TAC-TAA-TTC-TTC-TTG

68536–68567
70163–70193
68324–68358
69731–69763

1,657

This
This
This
This

study
study
study
study

capA

capA1F
capA2R
capA2F a
capCRa

CAA-CAT-TTG-CAA-TCA-TGA-ATA-TTT-ATT-ACT-TAT
AGT-TGT-TGT-CTC-CAC-TGA-TAC-TTG-ATT-TTC
CGG-ATT-ATG-GTG-CTA-AGG-GAA-CTA-AAG-A
CGC-AGC-TAT-TAA-TAT-AAC-TGC-GAT-AAG

55630–55662
54381–54410
55135–55162
55494–55520

1,291

This
This
This
This

study
study
study
study

capB

capB1F
capA1R
capB1Ra
capCF a

CTT-AAT-AAG-CAA-GAA-ATC-GAA-AAG-CAG-GAA-GG
AGG-CCT-TTA-TTG-TAT-CTT-TAG-TTC-CCT-TAG
CAA-GCG-ATG-CAT-TAT-CTG-GGA-AGA-CCA
GGA-AGA-ACA-AAT-TGG-CAA-AAA-GC

57294–57325
55121–55150
56631–56657
56106–56128

2,204

This
This
This
This

study
study
study
study

capC

capB2F
capA1R
capA1F a

GGT-CTT-CCC-AGA-TAA-TGC-ATC-GCT-TG
AGG-CCT-TTA-TTG-TAT-CTT-TAG-TTC-CCT-TAG
CAA-CAT-TTG-CAA-TCA-TGA-ATA-TTT-ATT-ACT-TAT

56631–56656
55121–55150
57294–57325

1,535

This study
This study
This study

capC

capCF
capCR
capB2Ra

GGA-AGA-ACA-AAT-TGG-CAA-AAA-GC
CGC-AGC-TAT-TAA-TAT-AAC-TGC-GAT-AAG
TTC-TTT-CTG-TAA-AAA-TAA-GGC-TCA-GTG-TAA-CTC-CT

56106–56128
55494–55520
56005–56039

635

This study
This study
This study

capC

RcapCF
RcapCR
capA1F a

ACT-CGT-TTT-TAA-TCA-GCC-CG
GGT-AAC-CCT-TGT-CTT-TGA-AT
CAA-CAT-TTG-CAA-TCA-TGA-ATA-TTT-ATT-ACT-TAT

55942–55961
55698–55717
57294–57325

264

23
23
This study

capD

dep1F
dep4R
dep2F a
dep3Ra

CGA-ACG-TTT-AAA-GGT-CCC-CAT-TGT
TTG-CGG-TTG-AGG-AAG-GTA-TGA-AA
ATC-GTT-TCC-CCA-TCT-TTC-TTT-AAT-ACA-GTG
CAT-ATT-GGA-GTA-CCC-GGA-TTT-GTG-G

52697–52720
54190–54212
53114–23143
53892–54006

1,600

This
This
This
This

study
study
study
study

capR

capR1F
repA1R
capR1Ra
capR2F a

GGC-GGG-TTT-TCC-TTT-GTT-CC
TGG-CAA-ACT-ATC-AGC-AAA-CAT-TTC-TCG-TA
ATG-GCT-AGC-GAT-TAT-GTT-CTT-GTT-GC
ATC-GCT-AGC-CAT-TGC-AGA-ACT-TTT-T

35917–35936
33528–33556
35507–35532
35494–35518

2,408

This
This
This
This

study
study
study
study

IS1627

IS1627F
IS1627R
ORF43-1a
ORF43-2 a

TAA-ACG-GGG-CAC-CTA-TTA-AAA-CAC-CTA-AA
TTG-AAG-CGT-CAG-TCC-CAA-ATG-AAA-AG
GGA-TAC-TTT-TGT-TAC-CTT-TTG-TGA-ATA-GAA
GAT-GAA-GAC-AGT-AAA-ACA-AGT-AAT-GAG-AGG

39718–39746
40171–40196
39814–39843
40016–40045

479

This
This
This
This

study
study
study
study

Promoter

procapF
procapR
procap-1a

AAA-TAA-TTG-CAA-TCT-TTG-GAT-CAG-AAT-CTA-A
AAG-AAA-AAC-GCA-ATT-TAC-AGA-ACT-CCT-CT
CTA-AGA-ATA-GAT-TTC-AAT-TTA-AAG-GGG-GTG

58104–58134
57684–57722
57894–57923

443

This study
This study

ORF 48

ORF48-F
ORF48-R
ORF48-1a

GGA-GGA-CAA-AGC-ATG-ACT-AAA-GTT-GAT-AAG-GTA-A
AAT-GTC-TCC-CCC-TCA-TAA-ACA-GAA-GAT-ACT-TTT-T
GCC-TAC-GAC-AAA-AGT-GGT-GAG-ATT-ATG-TGG

44465–44498
45130–45163
44645–44674

669

This study
This study
This study

ORF 61

ORF61-F
ORF61-R
ORF61-3a

CTT-TCT-CTG-TCT-TTA-CCG-ACC-TTT-TAT-ACT-CA
AGA-AAT-CAA-ATG-CCT-TCT-TTG-TCG-AT
CTT-AAC-CAA-TGC-TTG-GTA-TTG-CTG-TAA-ATC

62793–62824
63221–63426
62910–62939

459

This study
This study
This study

repA

repA1F
repA4R
repA2Ra
repA4F a

GAA-GAT-TTA-AGG-GCT-AAG-TTT-GGG-ACT-CG
GCC-CTT-CCA-ATA-TGC-CGT-ATA-GTG-TTT-C
TGA-AAA-CAC-GCT-AAA-GAA-AGG-GTG-AAA-AT
GCC-CTT-CCA-ATA-TGC-CGT-ATA-GTG-TTT-C

33913–33941
32591–32618
33211–33239
33006–33026

1,350

This
This
This
This

study
study
study
study

a
Oligonucleotide probes were internal to, and specific for, the target sequence as determined by N-blast with the NCBI library. Probes were used alone or with other
oligonucleotide in a “cocktail” for optimal results. Oligonucleotides were end labeled with digoxigenin by following the manufacturer’s directions. Probes were also used
for DNA-DNA hybridization of dot blots made from either genomic or plasmid DNA.
b
The position and orientation of each primer can be noted in Fig. 1.
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FIG. 1. Map of oligonucleotide primers and probes for selected genes and ORFs on pX02. The genes were selected because they have not been
previously described in the genomes or plasmids of Bacillus species other than B. anthracis, B. cereus, and B. thuringiensis.

quence similarity as a Bacillus sp. closely related to B. luciferensis.
CBD 118, although positive by the capsule DFA test, did not
display a visible capsule in India ink mounts by phase contrast
after growing overnight on TSA and/or BUG supplemented
with 0.8% sodium bicarbonate with 5% or approximately 20%
CO2 at 35°C. After growing in either concentration of CO2 on
media containing sodium bicarbonate, colonies of the positive
control CBD 63 (B. anthracis Pasteur) appeared to generate a
distinct wet coating. When observed microscopically, the cells
incubated in 5% CO2 produced obvious thin-to-moderate capsules on approximately 50% of cells per microscope field
(1,000⫻). When incubated at the higher CO2 concentration,
most of the bacterial cells seen per field possessed thicker
capsules. In contrast, the negative controls CBD 58 (B. cereus)
and CBD 389 (B. circulans) failed to produce discernible capsules under identical conditions. CBD 119 and CBD 980 (B.
luciferensis) failed to thrive on media supplemented with 0.8%
sodium bicarbonate. Therefore, they were tested after growing
on BUG or TSA plates without added CO2 or in 5% CO2.
Although CBD 119 was negative for the B. anthracis capsule by
DFA, the strain produced thin but omnipresent capsules with
or without CO2. CBD 980 failed to produce capsules under all
conditions tested.
After repeated testing of initial assay mixtures, CBD 118
and 119, as well as the original specimens from which they
came, were consistently positive by PCR for Ba813, pX02,
and the LRN chromosomal marker for B. anthracis, while
both isolates were negative for gamma phage susceptibility

and the B. anthracis cell wall by DFA (Table 1). Only CBD
118 was positive for the capsule by the initial DFA testing.
The test on CBD 118 was performed more than once since
it was an unexpected result. When the cryostock vials from
the original culture and the official CBD collection were
later subcultured (one or two passages) and examined, the
DFA results for both CBD 118 and 119 were negative. The
same DFA reagents were used throughout the tests although lot numbers did change.
Using previously published primers (23), we established that
the two Bacillus isolates also gave positive PCR results for
capC (Table 4). Labeled oligonucleotide probes designed from
the sequences of 11 ORFs that are located on pX02 hybridized
with the dot blots of total DNA and Southern blots of uncut
plasmid DNA (Table 4). Probes specific for chromosomal
DNA targets hybridized with the total DNA blots only. PCR
assays for the 11 ORFs yielded positive results for both isolates
(Table 4), while PCR for the chromosomal marker was consistently negative when using the plasmid DNA as a template.
Hybridization with labeled probes specific for internal sequences of the different ORFs confirmed that the PCR amplicons were the desired targets.
Both isolates carried a large plasmid that migrated the same
distance as the B. anthracis Pasteur (CBD 63) plasmid when
electrophoresed on a 0.7% agarose gel. DNA bands larger
than 23 kb were not easily resolved unless the DNA was electrophoresed for longer than 4 h. The uncut plasmid was usually
still supercoiled, migrated faster on the gels, and appeared to
be closer to the 23-kb position. Occasionally, the plasmid
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TABLE 3. Additional oligonucleotides used for sequencinga the capsule operon and related genesb in the two Bacillus spp.
Oligonucleotide

Sequence (5⬘33⬘)

Location

acpA1R
acpA2R
acpA4F
acpA5F
capA2F
RcapBCA-F
RcapBCA-Fcomp
RcapBCA-Rcomp
capB1F-comp
capR2R
dep1R
dep2R
dep3F
dep4F
dep4R-comp
procapRcomp
repA1Fcomp
repA2F
repA2Fcomp
repA3F
repA3R
repA5F
repA5R
orf61-2F
orf61-2R

TCA-ATT-TTT-CGG-CTA-ATA-TCT-TTT-TCC-ATA-ATT
ATA-ATT-TGA-AAT-TCA-TCC-CCT-ACA-ATT-CTT-AAT-G
TTT-ACA-AAG-AGG-GGG-AAA-GCA-CAA-CTT-A
TTG-CTT-ATT-ACC-GGT-GAA-GGA-AAA-AGT-TGG
CGG-ATT-ATG-GTG-CTA-AGG-GAA-CTA-AAG-A
GAA-ATA-GTT-ATT-GCG-ATT-GG
CCA-ATC-GCA-ATA-ACT-ATT-TC
CGT-ACA-GAA-GCA-GTA-GCA-CC
CCT-TCC-TGC-TTT-TCG-ATT-TCT-TGC-TTA-TTA-AG
TTT-TTG-GAG-GGA-TAC-ATA-TGG-AAC-ACA
GGC-CCC-CAC-TGT-ATT-AAA-GAA-AGA-T
ATG-ATG-TTT-ATA-CCG-CTC-CAC-CAC-CTT
ACG-TAA-TTT-GGA-TCC-CCT-AGG-TTT-TTC-T
TAA-GGT-TCT-CGC-TAA-ATC-TGT-CTG-GA
TTT-CAT-ACC-TTC-CTC-AAC-CGC-AA
AGA-GGA-GTT-CTG-TAA-ATT-GCG-TTT-TTC-TT
CGA-GTC-CCA-AAC-TTA-GCC-CTT-AAA-TCT-TC
AGG-CGG-TGT-ACG-TAT-CAA-ACA-ACA-AGA-ACT
AGT-TCT-TGT-TGT-TTG-ATA-CGT-ACA-CCG-CTT
GCC-TTC-CGT-GCG-CCT-TCT-GTA
GTT-AAG-CGC-TTC-GCA-CAG-TTC-TGA-T
ACG-TTC-CCC-GCA-GCA-CAT
TTT-ACC-CAA-TTT-TAG-CAC-CAC-CAA
TCA-GGT-ACA-TAA-TAA-AAG-CAG-AAA-GT
GAG-AGG-AGG-GTT-GTA-AAT-GAA-GTT

68905–68937
69318–69351
69747–69774
70103–70132
55135–55162
56315–56334
56315–56334
55462–55481
57294–57325
35004–35030
53125–53149
53580–53606
53423–53450
53752–53777
54190–54212
57684–57722
33913–33941
33596–33625
33211–33239
33242–33265
32856–32880
32840–32857
32366–32389
63089–63114
63826–63849

Reference

This
This
This
This
This
23
23
23
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This

study
study
study
study
study

study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study

a
In accordance with the manufacturer’s directions, oligonucleotides were used to generate sequences that were assembled using the SeqMan program of DNAStar.
In order to prevent potential PCR errors, sequences were determined multiple times in both directions.
b
The position and orientation of each primer can be noted in Fig. 1.

gether (23.206 and 62.129 kb). It is possible that this control
strain lost the restriction site to produce a 10.8-kb band from
the missing 3.184- and 7.712-kb bands. The digestion with MluI
produced two large intense bands that migrated closely together. These bands were hard to resolve unless electrophoresed for a much longer time. The small 2.136-kb band appears
to be missing. The PvuI digestion yielded one intense band in
which the 26.226-kb and 26.889-kb bands migrated together
and were closely followed by another large intense band
(31.282 kb). The expected 11.833-kb band was not seen on any
repeated digestions with PvuI, suggesting a loss of restriction
site. The XhoI digestion yielded two bands that migrated close
to the 23-kb position. A large 81.8-kb band was expected and
should have been visible and clearly distinct from the 23-kb
position. It is possible that the control strain has gained a
restriction site to produce the two bands. It appears from our
gels that the sequence of pX02 in the B. anthracis Pasteur
strain in our collection may have some differences from those
sequences in the databases upon which the digestions are

would get torn or nicked and would migrate much more slowly
and appear to be larger than the supercoiled DNA. When the
CBD 63 plasmid was digested with EcoNI and electrophoresed
on the gel, the two smallest DNA bands that were expected
(108 and 229 bp) never appeared in any of our attempts (Fig.
2). The bands may have migrated off the gels before the ladder
or larger bands were better resolved or the control strain may
have lost restriction sites. If loss of restriction sites occurred,
the small sections of DNA would still be attached to a larger
band and would probably not affect the migration of the larger
DNA band by any appreciable distance. The band at about 1.3
kb was seen as a very faint band on the gel and never was as
intense as the larger bands. The band expected at about 10.6 kb
was never seen in any EcoNI digestions, suggesting the loss of
another restriction site. The other six bands (3.328, 4.445,
8.487, 16.355, 18.608, and 32.658 kb) expected in the EcoNI
digestion were present (Fig. 2, lane 2). The digestion of CBD
63 with KpnI produced three, not four, DNA bands: a light one
at about 11 kb and two large ones that migrated closely to-

TABLE 4. Results of PCR, Southern, and dot blot hybridization for 10 ORFs and the capsule promoter of B. anthracis pX02
Result for indicated ORF or capsule promoter:
Strain

63
118
119
131

Organism

B. anthracis
B. circulans
Bacillus sp.
B. anthracis

ORF 38
(repA)

ORF 39
(capR)

ORF 43
(IS1627)

ORF 48

ORF 55
(capD)

ORF 56
(capA)

ORF 58
(capB)

ORF 57
(capC)

Capsule
promoter

ORF 61

ORF 64
(acpA)

ⴙ
ⴙ
ⴙ
ⴙ

ⴙ
ⴙ
ⴙ
ⴙ

ⴙ
ⴙ
ⴙ
ⴙ

ⴙ
ⴙ
ⴙ
ⴙ

ⴙ
ⴙ
ⴙ
ⴙ

ⴙ
⫹
ⴙ
ⴙ

ⴙ
ⴙ
⫾a
ⴙ

ⴙ
ⴙ
ⴙ
ⴙ

ⴙ
ⴙ
ⴙ
ⴙ

ⴙ
ⴙ
ⴙ
ⴙ

ⴙ
ⴙ
ⴙ
ⴙ

a
The dot blot hybridization was negative for capB, but PCR and subsequent hybridization of Southern blots were positive. Sequencing attempts revealed the full
sequence for capB in CBD 119.
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FIG. 2. Restriction enzyme-digested plasmid DNA on 0.7% agarose gels after electrophoresis. (A) B. anthracis CBD 63; (B) CBD 118;
(C) CBD 119. Lanes 1, 8, and 15, HindIII-digested Lambda DNA marker; lanes 2, 9, and 16, plasmid DNA digested with EcoNI; lanes 3, 10, and
17, plasmid DNA digested with KpnI; lanes 4, 11, and 18, plasmid DNA digested with MluI; lanes 5, 12, and 19, plasmid DNA digested with NotI;
lanes 6, 13, and 20, plasmid DNA digested with PvuI; lanes 7, 14, and 21, plasmid DNA digested with XhoI.

based, even though the sequences of the genes examined to
date are identical.
CBD 118 presented a very different restriction pattern than
that of CBD 63 (Fig. 2). All of the restriction enzyme digestions produced more DNA bands in CBD 118 than in CBD 63.
For EcoNI, there were 19 bands seen: 1 large intense band
⬎23 kb, 3 bands between 23 and 9.4 kb, 1 band close to 9.4 kb,
2 bands between 9.4 and 6.6 kb, 1 intense band about 6.6 kb, 3
bands between 6.6 and 4.4 kb, 1 band about 4.4 kb, 5 bands
between 4.4 and 2.3 kb, and 2 intense bands ⬍2.0 kb (Fig. 2).
The KpnI digestion produced nine bands (one band ⬎23 kb,
two bands between 23 and 9.4 kb, one band about 9.4 kb, two
bands between 9.4 and 6.6 kb, and three light bands ⬍4.4 kb),
while the MluI digestion produced seven bands (two bands
⬎23 kb, two bands midway between 23 and 9.4 kb, two close
bands about 9.4 kb, and one band ⬍4.4 kb. The NotI digestion
produced four bands (one band ⬎⬎23 kb, two bands close to 23
kb, and one band about 9.4 kb), while the PvuI digestion also
produced four bands (one band ⬎⬎23 kb, two bands ⬎23 kb,
and one band about 9.4 kb). Lastly, the XhoI digestion yielded
three bands (one band ⬎⬎23 kb, one band close to but more
than 23 kb, and one band about 9.4 kb). The number of DNA
bands and very different intensities seen in the DNA bands
suggest that there may be more than one large plasmid present
or that the plasmid is much larger than pX02 (Fig. 2).
The restriction pattern of the CBD 119 plasmid was similar
but not identical to that obtained from B. anthracis CBD 63
(Fig. 2). Two extra bands were seen in the EcoNI digestion,
one at the 23-kb position and one slightly larger. There appears

to be one extra band (about 8 kb) in the KpnI digestion,
yielding a total of four bands (about 8 kb, 10 kb, 23 kb, and
perhaps 62 kb). The MluI and PvuI digestions appeared to
produce the same number of DNA bands of similar sizes and
intensities for CBD 119 as for CBD 63 (Fig. 2). The digestion
with XhoI produced two bands like the digestion of CBD 63
plasmid, but the smaller band is slightly more clearly separated
from the larger band, and it is more intense. There was one
large band sometimes seen in the NotI digestion that migrated
much more slowly, migrating to the same location as the large
band seen in the NotI, PvuI, and XhoI digestions of CBD 118;
it appears to be either a nicked or torn plasmid.
On Southern blots made from enzyme-digested plasmids,
the labeled probes hybridized to bands of similar sizes for CBD
63 and 119 although it was not always clear which of two closely
migrating bands hybridized with the probe (Fig. 3). When we
probed the Southern blots made from CBD 118 digested DNA
for specific genes, the oligonucleotide probes hybridized with
different-size bands than seen with CBD 63. For example, in all
of the digestions with EcoNI, KpnI, MluI, and NotI, the capC
oligonucleotide probes hybridized with the faster, smaller,
more intense bands of CBD 118 and not with the larger bands
as was seen with both CBD 63 and 119 (Fig. 3). The larger
bands seen in the PvuI and XhoI digestions did not consistently
hybridize with the capC probe, suggesting that not all of the
plasmid copies in the reaction tubes were fully cut when these
two digestions were performed.
Using different oligonucleotide primer combinations, we
were able to sequence 100% of the 10 genes and most (97.3%)
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FIG. 3. Hybridization of Southern blotted membranes of digested plasmid DNA with capC oligonucleotide probe. (A) B. anthracis CBD 63;
(B) CBD 118; (C) CBD 119. Lanes 1, 7, and 13, plasmid DNA digested with EcoNI; lanes 2, 8, and 14, plasmid DNA digested with KpnI; lanes
3, 9, and 15, plasmid DNA digested with MluI; lanes 4, 10, and 16, plasmid DNA digested with NotI; lanes 5, 11, and 17, plasmid DNA digested
with PvuI; lanes 6, 12, and 18, plasmid DNA digested with XhoI.

of the capsule promoter from CBD 118 and 119 and the two B.
anthracis strains (CBD 63 and 131). When the sequences were
assembled and compared against published sequences in the
NCBI library, the sequences of the nine genes (acpA, capA,
capB, capC, capR, IS1627, ORF 48, ORF 61, and repA) from
CBD 118 and 119 had 100% nucleotide identity and 100%
amino acid identity with four B. anthracis pX02 sequences in
GenBank, B. anthracis Pasteur (accession number NC_002146.1), B.
anthracis Ames (accession number AE017335.3), B. anthracis A2012
(accession number AE011191.1), and B. anthracis (accession number
AF188935.1) (01/06).
The only differences were seen in the capD and capsule
promoter sequences. The sequences for the capD genes from
CBD 118 and 119 had a single nucleotide substitution (A3G)
at position 53138 (based upon GenBank accession number
NC_002146.1) when compared to B. anthracis (accession number AF188935.1) and B. anthracis Pasteur (accession number
NC_002146.1 (Fig. 4) (01/06). This substitution is also seen in
CBD 63, CBD 131, B. anthracis A2012 (accession number

AE011191.1), and B. anthracis Ames (accession number
AE017335.3. However, the amino acid sequences encoded by
capD are identical. The capsule operon promoters of both
CBD 118 and 119 had identical single base pair substitutions at
two different locations (Fig. 5). At position 57837 (based upon
NC_002146.1), CBD 118 and 119 show one base pair substitution (A3G). This differs from AE011191.1 and AE017335,
yet matches the other B. anthracis sequences. The second base
pair substitution is at position 58137 (based upon the GenBank
sequence of NC_002146.1), where CBD 118 and 119 have a
cysteine (C) matching CBD 63 and 131 instead of a thymine
(T) as seen in the other four sequences (NC_002146.1,
AF188935.1, AE011191.1, and AE017335) (Fig. 5) (01/06).
DISCUSSION
Here we report the presence of 10 genes, including the
capsule operon of the B. anthracis plasmid pX02, on two different large plasmids in a B. circulans and a Bacillus species

FIG. 4. Partial sequence of the capD gene showing a single base pair difference. At position 53183 (based upon the GenBank sequence of
NC_002146.1), CBD 118 and 119 match four of the six sequences of the pX02 of B. anthracis but are different from the other two GenBank
sequences (A3G) (AF0188935.1 and NC_002146.1). CBD 63 is B. anthracis Pasteur strain, CBD 118 is B. circulans, CBD 119 is a Bacillus sp., and
CBD 131 is B. anthracis. Strains designated AF188935.1 (B. anthracis), AE011191.1 (B. anthracis A2012), AE017335.3 (B. anthracis Ames), and
NC_002146.1 (B. anthracis Pasteur) are the sequences available in GenBank for the B. anthracis pX02 plasmid.
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FIG. 5. Two partial sequences of the capsule operon promoter showing a single base pair difference at each location. At position 57837 (based
upon the GenBank sequence of NC_002146.1), CBD 118 and 119 match four of the six sequences of the pX02 of B. anthracis and differ from the
other two sequences (A3G). At position 58137 (based upon the GenBank sequence of NC_002146.1 CBD 118 and 119 have a cysteine
(C) matching CBD 63 and 131 instead of a thymine (T) as the other sequences from GenBank have. CBD 63 is B. anthracis Pasteur strain, CBD
118 is B. circulans, CBD 119 is a Bacillus sp., and CBD 131 is B. anthracis. AF188935 (B. anthracis), AE011191.1 (B. anthracis A2012), AE017335
(B. anthracis Ames), and NC_002146.1 (B. anthracis Pasteur) are the sequences available on GenBank for the B. anthracis pX02 plasmid.

distinct from but closely related to B. luciferensis. To our
knowledge, this is the first time large plasmids with these genes
have been identified in Bacillus species not of the B. cereus
group. We have shown that a large plasmid in B. circulans
(CBD 118) is different from the pX02 plasmid by restriction
enzyme pattern using a total of five restriction enzymes, yet this
plasmid carried all of the genes targeted in this study. It is
possible that there is more than one large plasmid present in
CBD 118. This would explain the high number of large DNA
bands seen in the digestions and also the very different intensities seen in the DNA bands. One predominant plasmid of
high copy number may be masking the presence of a second
plasmid. This could also be why the NotI, PvuI, and XhoI
digestions produced a large band that is seen migrating much
more slowly than other large DNA bands. However, the hybridization studies suggest that the high-copy-number plasmid
with the distinctive restriction digestion pattern carries the
different pX02 genes. This finding implies that there may be
other large plasmids that carry the pX02 genes.
We have also shown that the plasmid found in CBD 119, the
Bacillus isolate not yet fully identified, has a similar restriction
enzyme pattern as pX02 in our B. anthracis Pasteur strain. This
plasmid appears to have two EcoNI restriction sites and one
KpnI restriction site more than the B. anthracis isolate. Yet,
our control B. anthracis also appeared to lose an EcoNI, a
KpnI, and a PvuI restriction site and to gain an XhoI site,
suggesting that the large plasmid in CBD 119 may still in fact
be pX02. This may not be surprising, since pX02 has previously
been identified in B. cereus isolates, but this is the first time that
a plasmid carrying the pX02 virulence genes has been found in
a Bacillus isolate that is not related to B. anthracis or B. cereus.
Further work will determine the magnitude of similarity this
plasmid has to pX02. We plan to look for more pX02 genes in
this plasmid and to eventually fully sequence the two plasmids.
Other studies to be undertaken are to explore why the capsule

is not expressed although the capsule genes are present and to
determine if there is any interaction between these plasmids
and the chromosome. Animal studies of these two isolates and
the plasmids described above would be additional areas of
exploration.
The prevalence of these plasmids in other species of Bacillus
is not known. Nor is it known if these plasmids are restricted to
the Bacillus genus. We can only speculate as to how or when
the two Bacillus isolates obtained the two plasmids, although
other researchers report that horizontal transfer of plasmids
occurs in Bacillus spp. by conjugation and transduction (2, 24).
This raises the possibility that the plasmids could be mobile in
other Bacillus species and suggests that more individual isolates of different Bacillus species may also carry the pX02
plasmid or like plasmids. The facts that the sequences of the 10
genes had 100% nucleotide and amino acid identity over the
entire lengths of the genes with 9 of the B. anthracis pX02
genes and that the nucleotide difference in capD did not result
in different amino acids imply not only that the genes are
functional but also that the plasmids have been recently introduced into these two isolates. Mobility of the two plasmids has
not yet been studied.
The DFA results were intriguing since they suggest that the
B. circulans isolate (CBD 118) expressed an epitope similar to
the B. anthracis capsule epitope that is recognized by the test
antibody. However, after further culturing, retests using the
same reagents with the same and different lot numbers were
negative, implying that the ability to express the same epitope
was impaired. The Department of Health personnel who performed this test on the isolates are very experienced, and they
repeated the assessment at the initial testing. In addition, other
personnel also examined the slides and agreed that the DFA
test was positive. Therefore, we have full confidence that the
test was performed correctly and that the epitope was initially
expressed. This suggests a number of possibilities: (i) an envi-
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ronmental change or lack of host-specific factor inhibited capsule expression, (ii) the organism can only express the capsule
under specific conditions, (iii) the organism may have a deficiency in the secretion of the capsule, or (iv) regulation of
capsule production may differ from B. anthracis.
It is possible that the temperatures and the media used were
not optimal for the strain to produce the capsule. CBD 118 and
119 both grew luxuriantly at 30 to 35°C, and, although temperature tolerance was tested, the normal temperatures for culture incubation were not above 37°C. We used TSA and BUG,
both supplemented with sodium bicarbonate, before performing India ink mounts and did not examine other media. The
FDOH personnel used bicarbonate-supplemented media and
horse serum when performing the antibody tests for the capsule. The incubator temperature used was 35 ⫾ 2°C. Therefore, it is possible that the temperature was higher in the initial
test and lower in subsequent tests. Other researchers have
found that isolates that do not carry the pX01 plasmid needed
incubation in 20% CO2 in order to express the capsule (12). In
fact, their strains did not express the capsule when incubated in
5% CO2 even when sodium bicarbonate was added to the
media. However, our B. anthracis strain (CBD 63) carries only
pX02 and expressed the capsule, as seen by both gross examination of colonies and microscopic inspection of India ink
mounts, regardless of whether or not the strain was incubated
with 5% or 20% CO2. Even at 20% CO2, CBD 118 did not
produce any capsule material that we could detect microscopically. Further examination of this organism’s capsule operon
and its regulation may help us understand what has occurred.
In addition, if growth parameters and other conditions can be
adjusted and result in capsule formation, we will attempt to
directly analyze the capsule material. It is possible that CBD
118 is able to change the epitope or switch from one isomer to
another. B. anthracis produces only the D isomer of glutamic
acid (30), but perhaps B. circulans cannot normally do this
easily and may switch to a mixture or to the L form. This would
explain why the DFA results changed from positive to negative, but it does not explain why India ink did not detect a
capsule since this test is not based on a specific molecular
epitope. The bacterial cell may produce the capsule but may
have difficulty in secreting the material to the exterior of the
cell. The first positive DFA tests may have been performed on
colonies that had lysed cells where the capsule components
were released into the environment. Lastly, it may be noteworthy that we had difficulty in sequencing the full promoter sequence of the capsule operon, especially since there was a
difference in the nucleotide sequence in both isolates. Perhaps
the full promoter sequence is not present. This may explain
why the capsule was not expressed in CBD 119, but not why it
appeared to be expressed in CBD 118 initially.
The capsule of CBD 119 seen with India ink has not yet been
analyzed. Because the antibody tests have been consistently
negative for this isolate, the capsule could be composed of
different material from that of B. anthracis, even though the B.
anthracis capsule operon is present. There may be competition
between the production and secretion of the native (Bacillus
sp.) capsule material and the “foreign” (B. anthracis) capsule
material. This will also be addressed in future studies.
While culturing is the “gold standard” for the isolation and
identification of B. anthracis, PCR targeting for the virulence
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genes on pX01 and pX02 is normally employed as one of the
first steps in the LRN protocols for the rapid presumptive
detection of B. anthracis in a credible-threat environmental or
clinical sample. For example, the genes in the capsule operon
have long been successfully exploited for identifying the pX02
plasmid in such testing. However, the Tampa laboratory still
identified 19 isolates that were positive for the chromosomal
marker and the pX02 plasmid by the LRN protocol and considered the specimens to carry B. anthracis until further testing
was performed. In addition, the FDOH laboratory has had
specimens that tested positive for the pX02 target and negative
for the other targets (chromosomal and pX01) although the
exact number of these types of specimens is not known. In our
collection of 300 soil, environmental, and clinical isolates of
different Bacillus species of the B. cereus group (not including
B. anthracis), we have 73 isolates that are positive for only
Ba813 and 17 isolates with both Ba813 and pX02. It is also
unknown how many other species of Bacillus in the environment have large plasmids that carry these virulence genes or
other genes normally found in pX02. To our knowledge, a
systematic search for this plasmid or genes in the general soil
bacterial population has not been undertaken.
The LRN protocol uses three targets—the first on the chromosome, the second on pX01, and the third on pX02—to
determine the presence of B. anthracis in environmental samples. After a colony is confirmed to be B. anthracis by gamma
phage assay and DFA, PCR assays are used to confirm the
presence of the two plasmids. For detection and identification
purposes, the three targets (whether individually present or
absent) are equally important. We do not suggest that the LRN
discontinue testing for the pX02 plasmid because cases in
which a Sterne or Pasteur strain was used would be missed. If
there were a real biothreat event, the LRN would attempt to
characterize fully the strain of B. anthracis involved and determine the danger to exposed persons. Yet the fact that 11
sequences that we analyzed are not limited to pX02 or to the
B. cereus group raises questions about the usefulness of these
sequences for detection. Perhaps other sequences carried on
pX02 would be better targets for the molecular detection of B.
anthracis, targets that are truly unique to this pathogen.
Whether there is a sequence on pX02 that is limited to B.
anthracis remains to be seen and will be further evaluated as
we compare the plasmids from these two isolates to pX02. In
conclusion, the presence of these capsule genes in two soil
Bacillus species other than B. anthracis alerts us to the necessity of identifying additional genes or sequences that will signal
the presence of B. anthracis in forensic, clinical, and environmental samples.
ACKNOWLEDGMENT
This work was supported by the U.S. Army Research, Development
and Engineering Command, contract DAAD 13-01-C-0043.
REFERENCES
1. Altschul, S. F., T. L. Madden, A. A. Schäffer, J. Zhang, Z. Zhang, W. Miller,
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